April 2007

 

 
MassMEDIC Notes




Bedford, Massachusetts-based MicroCHIPS recently received $13.4 million in funding from Novartis Venture Fund and CSK Venture Capital of Japan. The two organizations’ investment will help support MicroCHIPS’ development of implantable biosensing and drug delivery devices designed to improve therapeutic control and reduce painful interventions for diabetes and osteoporosis patients…Myomo’s robotic therapy device is featured in the April edition of the American Journal of Physical Medicine and Rehabilitation. Results of a pilot study held at the Spaulding Rehabilitation Program demonstrated a statistically significant and clinically relevant improvement in upper arm function with using the technology…Boston Scientific recently announced Japanese regulatory approval for its Vitality DR implantable cardioverter defibrillator (ICD). According to the company, the Vitality system is the smallest dual chamber ICD available in Japan.